Drug-coated balloons: technologies and clinical applications

H Ang, J Lin, YY Huang, TT Chong… - Current …, 2018 - ingentaconnect.com
The progress and development of drug-coated balloons (DCBs) represents an emerging
alternative treatment in peripheral and coronary artery diseases, particularly when a non …

[HTML][HTML] Review of the latest percutaneous devices in critical limb ischemia

L Haghighat, SE Altin, RR Attaran… - Journal of Clinical …, 2018 - mdpi.com
Critical limb ischemia (CLI) is a terminal stage of peripheral arterial disease that, in the
absence of intervention, may lead to lower extremity amputation or death. Endovascular …

Characteristics and clinical outcomes of repeat endovascular therapy after infrapopliteal balloon angioplasty in patients with critical limb ischemia

N Kobayashi, K Hirano, M Yamawaki… - Catheterization and …, 2018 - Wiley Online Library
Objectives We clarified characteristics and clinical outcomes of critical limb ischemia (CLI)
patients who underwent repeat endovascular therapy (EVT) for infrapopliteal lesions …

Drug-coated balloon angioplasty for the management of recurring infrapopliteal disease in diabetic patients with critical limb ischemia

LM Palena, LJ Diaz-Sandoval… - Cardiovascular …, 2018 - Elsevier
Objective To describe the 1-year outcomes of recurring infrapopliteal disease after
endovascular revascularization with the Lutonix drug-coated balloons (LDCB) in diabetic …

Comparison of drug eluting balloon angioplasty to infrapopliteal artery critical lesions with or without additional pedal artery angioplasty in patients with diabetes …

B Teymen, S Aktürk - 2018 - Wiley Online Library
Background The purpose of this study is to investigate the feasibility and outcome of balloon
angioplasty for the treatment of below the ankle (BTA) lesions in addition to below the knee …

A universal drug delivery catheter for the treatment of infrapopliteal arterial disease: results from the multi‐center first‐in‐human study

F Bunch, C Walker, E Kassab… - Catheterization and …, 2018 - Wiley Online Library
Objective The objective of this study was to assess the feasibility, safety and initial efficacy of
paclitaxel administration using a novel drug delivery catheter for the prevention of restenosis …

Increased plasma olfactomedin 2 after interventional therapy is a predictor for restenosis in lower extremity arteriosclerosis obliterans patients

H Li, H Gui, G Yuan, X Zheng, C Gao… - Scandinavian Journal of …, 2018 - Taylor & Francis
Animal studies have indicated that olfactomedin 2 (OLFM2) is involved in the process of
vascular remolding. The aim of the present study was to investigate circulating OLFM2 levels …

Thirty-six-month outcomes of drug-eluting balloon angioplasty in the infrapopliteal arteries

B Ozpak, S Bozok, MC Cayir - Vascular, 2018 - journals.sagepub.com
Objectives To evaluate 36-month outcomes of drug-eluting balloons in infrapopliteal (=
below-the-knee) arterial segments, we made a prospective registry enrolling patients …

Drug-delivering endovascular treatment versus angioplasty in artery occlusion diseases: a systematic review and meta-analysis

X Chen, J Li, C Zheng, Y He, J Jia, X Wang… - Current Medical …, 2018 - Taylor & Francis
Objective: The best management of patients with femoropopliteal and infrapopliteal artery
occlusion disease is not clear. This study aimed to compare the efficacy of drug-coated …

[PDF][PDF] Endovascular procedures in treatment of infrapopliteal arterial occlusive disease: single center experience with 69 infrapopliteal procedures

PJ Janko, BB Nebojsa, PV Andrej - Archives of Iranian Medicine, 2018 - journalaim.com
Background: Peripheral arterial occlusive disease (PAD) includes acute and chronic
disorders of the blood supply as a result of obstruction of blood flow in the arteries of the …